Evidence map›Paper›PMID 34199184›Full record

ArticleInternational journal of environmental research and public health2021

The Impact of the COVID-19 Pandemic on the Perception of Health and Treatment-Related Issues among Patients with Phenylketonuria in Poland-The Results of a National Online Survey.

Dariusz Walkowiak, Bożena Mikołuć, Renata Mozrzymas, Łukasz Kałużny, Bożena Didycz, Dorota Korycińska-Chaaban, Michał Patalan, Joanna Jagłowska, Agnieszka Chrobot, Ewa Starostecka and 2 more

Open access · goldAbstract read
In one paragraph

Article in International journal of environmental research and public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 9 institutions in 1 country.

Dariusz WalkowiakDepartment of Organization and Management in Health Care, Poznan University of Medical Sciences, Przybyszewskiego 39, 60-356 Poznan, Poland.ORCID 0000-0001-8874-2401
Bożena MikołućDepartment of Pediatrics, Rheumatology, Immunology and Metabolic Bone Diseases, Medical University of Bialystok, 15-274 Bialystok, Poland.ORCID 0000-0002-8284-6426
Renata MozrzymasResearch and Development Center, Regional Specialist Hospital, 51-124 Wrocław, Poland.
Łukasz KałużnyDepartment of Pediatric Gastroenterology and Metabolic Diseases, Poznan University of Medical Sciences, 61-701 Poznan, Poland.
Bożena DidyczOutpatient Metabolic Clinic, University Children's Hospital, 30-663 Krakow, Poland.
Dorota Korycińska-ChaabanPKU Polyclinic, Institute of Mother and Child, 01-211 Warsaw, Poland.
Michał PatalanDepartment of Pediatrics, Endocrinology, Diabetology, Metabolic Diseases and Cardiology, Pomeranian Medical University, 70-204 Szczecin, Poland.ORCID 0000-0002-5981-6456
Joanna JagłowskaDepartment of Pediatrics, Hematology and Oncology, Medical University of Gdansk, 80-210 Gdansk, Poland.
Agnieszka ChrobotVoivodship Children Hospital, 85-667 Bydgoszcz, Poland.
Ewa StarosteckaThe Regional Center of Rare Diseases, Polish Mother's Memorial Hospital Research Institute, 93-338 Lodz, Poland.
Joanna ZarębskaUpper Silesian Child Health Centre, 40-752 Katowice, Poland.
Jarosław WalkowiakDepartment of Pediatric Gastroenterology and Metabolic Diseases, Poznan University of Medical Sciences, 61-701 Poznan, Poland.ORCID 0000-0001-5813-5707
Poznan University of Medical Sciences · PLGdańsk Medical University · PLKatowice School of Economics · PLŁukasiewicz Research Network – PORT Polish Center for Technology Development · PLMedical University of Białystok · PLPolish Mother’s Memorial Hospital Research Institute · PLPomeranian Medical University · PLUniversity of Bydgoszcz · PLUniwersytecki Szpital Dziecięcy · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is agreement that the pandemic has affected the healthcare system and behaviour of patients. This study aims to identify problems encountered by patients with phenylketonuria (PKU) and their parents/caregivers during the six-week pandemic lockdown in Poland (15 March to 30 April 2020). To determine the factors that influenced health and treatment-related issues, as well as the respondents' perception of the impact of the pandemic, study participants were asked to complete a non-validated online questionnaire comprising 31 questions (including 27 single-choice, two multiple-choice and two open-ended ones). A total of 571 patients or their parents completed the questionnaire, with 9.5% of respondents not performing any blood phenylalanine (Phe) test in the analysed period, 21.3% declaring a blood Phe increase, and 15.3% a decrease. Increased problems in contacting the doctor or dietitian were reported by 26.1% of subjects, whereas 39.3% of them felt restricted access to dietary products. Most (63.4%) participants were satisfied with remote contact with their PKU clinic. Better compliance was associated with higher odds of acceptance of remote contact and of reporting fewer problems with contacting the doctor, and with lower odds of missing Phe testing. Self-reported high stress was associated with higher odds of reporting the limited availability of low-Phe products and Phe-free formulas, as well as with increased Phe concentrations and non-PKU-related health problems. These patients also had poor dietary compliance and experienced more problems in contacting specialists. Health and treatment-related problems experienced during the pandemic lockdown were related to a higher intensity of stress in patient's family and worse therapy compliance before the pandemic. Previous experience of remote visits resulted in a better perception of this method of contact. It seems that this form of communication should be popularized and improved to increase therapy effectiveness in case of different limitations in the future. Special attention should be paid to vulnerable patients who may be at extra risk when the provision of standard care is affected.

Indexed as

COVID-19PhenylketonuriasCommunicable Disease ControlHumansPandemicsPerceptionPolandSARS-CoV-2complianceCOVID-19 pandemicphenylketonuriaPKUremote medicine

Identifiers

PMID34199184
PMCPMC8296241
OpenAlexW3166620071

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.